老年人肉症营养风险指数的预测性表现:一个元分析
Dunan Xie1, Tianjin Huang2, Chuhua Yang1
1Jiangxi Medical College, Nanchang University, Nanchang Jiangxi 330006, China; Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang Jiangxi 330006, China.
Archives of gerontology and geriatrics
|August 18, 2025
概括
老年营养风险指数 (GNRI) 有效地预测了老年人肉症 (SP) 的风险. 较高的GNRI分数与发展SP的几率明显降低有关,有助于早期检测和干预.
科学领域:
- 老年学是一门学科.
- 营养科学 营养科学
- 老年医学 老年医学
背景情况:
- 麻症 (SP) 是一种与年龄相关的严重疾病,影响老年人肌肉质量,力量和功能.
- 它会对生活质量和预后产生负面影响.
- 老年营养风险指数 (GNRI) 是一种营养评估工具,但其在肉症中的预测作用尚未确立.
研究的目的:
- 评估老年营养风险指数 (GNRI) 对皮症 (SP) 的预测性能.
- 评估GNRI与老年人群中肉症风险之间的关联.
主要方法:
- 对11项涉及9707名参与者的观察性研究进行了系统的元分析.
- 数据来源于PubMed,Embase,Cochrane图书馆和科学网络.
- 使用NOS和AHRQ工具评估偏差风险;使用STATA 15.1.1.进行统计分析.
主要成果:
- 较高的GNRI得分与较低的肉症风险显著相关 (OR = 0.22,95% CI:0.13-0.35).
- 在GNRI中增加1个单位与萨尔科佩尼亚风险降低6.9%相关.
- 剂量反应分析证实,增加的GNRI与降低的肉症风险有关.
结论:
- 老年营养风险指数 (GNRI) 是一种有价值的萨尔科佩尼亚 (SP) 预测指标.
- GNRI有助于早期识别患有肉类的高风险个体.
- 建议进行进一步的研究,以完善GNRI的应用并验证其预测能力.
相关概念视频
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...